Skip to main content
. 2016 Sep 19;6(9):e230. doi: 10.1038/nutd.2016.36

Table 2. Adverse effects in both groups.

Symptomsa V2 (15 days)
V9 (4 months)
  VLCK diet group (n=45) LC diet group (n=44) P-value VLCK diet group (n=45) LC diet group (n=44) P-value
Asthenia 7 0 0.0092 1 0 0.3396
Headache 9 1 0.0124 2 0 0.1739
Nausea 9 0 0.0028 3 0 0.0936
Vomiting 7 0 0.0092 1 0 0.3396
Constipation 2 0 0.1772 8 0 0.0046
Cramps 1 0 0.3429 0 0
Myalgia 1 0 0.3429 1 0 0.3396
Muscular weakness 1 1 0.9328 0 0
Heaviness and tiredness of legs 1 1 0.9328 0 0
Hair loss 1 0 0.3429 2 0 0.1739
Orthostatic hypotension 0 0 6 0 0.0155
Edema 0 0 1 0 0.3396
Othersb,c 20 4 0.0004 5 8 0.0731
             
Patients lost
 Due to side-effects 0 0   1 0  
 Voluntary dropout 0 4   4 4  
 Total dropout   5 8  

Abbreviations: LC diet, low-calorie diet; VLCK diet, very low-calorie-ketogenic diet

.

a

All values show the number of patients.

b

Other adverse effects described in V2: anxiety, cold, diarrhea, epigastric pain, shoulder pain, halitosis, hunger, hypoglycemia, sachets intolerance, bad taste, dizziness, bloating, paresthesia, dry mouth, allergic rhinitis, nasal trauma.

c

Other effects described in V9: cold, abdominal pain, back pain, halitosis, diarrhea, urinary tract infection, increased blood pressure, palpitations.